首页 | 本学科首页   官方微博 | 高级检索  
     


Reimbursement for therapeutic apheresis devices and procedures for using the healthcare insurance system in Japan
Authors:Makio Kusaoi  Go Murayama  Naoto Tamura  Ken Yamaji
Abstract:The aim of this paper was to explain the insurance coverage status of therapeutic apheresis (excluding CHDF) in Japan, alongside the social system of medical reimbursement and concerns regarding the future sustainability of the healthcare system. Insurance schemes and premiums differed for individuals at different levels in the society (eg, municipal residents, employees, and public servants). Insurance premiums and their rates varied depending on the total household income, the number of people living together, age, and the place of residence. In addition, the medical expense subsidies for children through public expenditure were also described. Japan's generous insurance system and multiple medical expense subsidies provide financial support for patients. With Japan's history of medical expense subsidies based on the policy of supporting intractable diseases, we have established an environment where all citizens can receive therapeutic apheresis when needed if they are affected by a disease for which insurance coverage is indicated.
Keywords:apheresis  health expenditures  major medical insurance  out of pocket payments  reimbursement mechanisms
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号